METOPiRONE (Laboratoire HRA Pharma)
Welcome to the PulseAid listing for the METOPiRONE drug offered from Laboratoire HRA Pharma. This Adrenal Steroid Synthesis Inhibitor [EPC],Adrenal Steroid Synthesis Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Laboratoire HRA Pharma |
| NON-PROPRIETARY NAME: | Metyrapone |
| SUBSTANCE NAME: | METYRAPONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Adrenal Steroid Synthesis Inhibitor [EPC],Adrenal Steroid Synthesis Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE, GELATIN COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-08-14 |
| END MARKETING DATE: | 0000-00-00 |
METOPiRONE HUMAN PRESCRIPTION DRUG Details:
| Item Description | METOPiRONE from Laboratoire HRA Pharma |
| LABELER NAME: | Laboratoire HRA Pharma |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/1) |
| START MARKETING DATE: | 2014-08-14 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 76336-455_0c606a06-ed38-4079-a887-af07de15f252 |
| PRODUCT NDC: | 76336-455 |
| APPLICATION NUMBER: | NDA012911 |
Other METYRAPONE Pharmaceutical Manufacturers / Labelers:
